Hepion Pharmaceuticals
(NASDAQ:HEPA)
$0.385
-0.0148[-3.70%]
Last update: 2:13PM (Delayed 15-Minutes)
Get Real Time Here
Day Range0.37 - 0.452 Wk Range0.36 - 1.33Open / Close0.39 / -Float / Outstanding76.1M / 76.2M
Vol / Avg.227.3K / 173KMkt Cap29.3MP/E-50d Avg. Price0.49
Div / Yield-Payout Ratio-Total Float76.1MEPS-0.11

Hepion Pharmaceuticals Stock (NASDAQ:HEPA), Quotes and News Summary

Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.

Loading...
Day Range0.37 - 0.452 Wk Range0.36 - 1.33Open / Close0.39 / -Float / Outstanding76.1M / 76.2M
Vol / Avg.227.3K / 173KMkt Cap29.3MP/E-50d Avg. Price0.49
Div / Yield-Payout Ratio-Total Float76.1MEPS-0.11
InvestorsObserver - Apr 25, 2022, 7:01AM
InvestorsObserver - Mar 28, 2022, 8:57AM
Seeking Alpha - Jan 27, 2022, 3:10AM
Seeking Alpha - Jan 21, 2022, 12:37PM
Seeking Alpha - Nov 30, 2021, 8:28AM
Sector: Health Care.Industry: Pharmaceuticals
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.110
REV0
Q2 2022Est.ActualSurprise
EPS-0.260
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Hepion Pharmaceuticals (HEPA) stock?

A

You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hepion Pharmaceuticals's (HEPA) competitors?

Q

What is the target price for Hepion Pharmaceuticals (HEPA) stock?

A

The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Cantor Fitzgerald on Monday, February 28, 2022. The analyst firm set a price target for 3.50 expecting HEPA to rise to within 12 months (a possible 809.09% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Hepion Pharmaceuticals (HEPA)?

A

The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.385 last updated Today at November 28, 2022, 7:13 PM UTC.

Q

Does Hepion Pharmaceuticals (HEPA) pay a dividend?

A

There are no upcoming dividends for Hepion Pharmaceuticals.

Q

When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?

A

Hepion Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q

Is Hepion Pharmaceuticals (HEPA) going to split?

A

There is no upcoming split for Hepion Pharmaceuticals.

Q

What sector and industry does Hepion Pharmaceuticals (HEPA) operate in?

A

Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.